Haemonetics (HAE) Long-Term Deferred Tax (2010 - 2026)

Haemonetics' Long-Term Deferred Tax history runs 17 years deep, the most recent figure standing at $9.5 million for Q1 2026.

• In Q1 2026, Long-Term Deferred Tax rose 22.02% year-over-year to $9.5 million; the TTM figure through Mar 2026 stood at $9.5 million (up 22.02% YoY), while the FY2026 annual figure was $9.5 million, up 22.02% from the prior year.
• Long-Term Deferred Tax was $9.5 million for Q1 2026 at Haemonetics, up from $7.3 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $9.5 million in Q1 2026 to a low of $4.3 million in Q4 2022.
• Historically, Long-Term Deferred Tax has averaged $6.6 million across 5 years, with a median of $6.7 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Long-Term Deferred Tax decreased 29.39% in 2022, then surged 92.18% in 2024.
• A 5-year view of Long-Term Deferred Tax shows it stood at $4.8 million in 2022, then increased by 4.71% to $5.1 million in 2023, then jumped by 57.79% to $8.0 million in 2024, then decreased by 8.39% to $7.3 million in 2025, then increased by 29.91% to $9.5 million in 2026.
• The last three Long-Term Deferred Tax figures came in at $9.5 million (Q1 2026), $7.3 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.